**Question:** Filgrastim is a :

Core Concept:
Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) used to stimulate the production of white blood cells in patients with chemotherapy-induced neutropenia. It is a biological response modifier that aids in the recovery of neutrophils following chemotherapy or radiation therapy.

Why the Correct Answer is Right:
Filgrastim belongs to a group of drugs known as granulocyte colony-stimulating factors (G-CSFs). G-CSFs are used to stimulate the production of white blood cells, particularly neutrophils, which are crucial for defending the body against infections. Filgrastim specifically targets the bone marrow to increase the production of neutrophils, thus aiding in their recovery after chemotherapy or radiation therapy, which can have a detrimental effect on the immune system.

Why Each Wrong Option is Incorrect:
A. Neutropenia refers to a decrease in neutrophil count, not a drug. G-CSFs like filgrastim are used to address neutropenia, not cause it.
B. Filgrastim is a G-CSF, not a monoclonal antibody. Monoclonal antibodies like rituximab are used to target specific cells or proteins, whereas G-CSFs like filgrastim stimulate the production of white blood cells.
C. Filgrastim is a G-CSF, not a corticosteroid. Corticosteroids have anti-inflammatory and immunosuppressive properties, which are different from the action of G-CSFs.
D. Filgrastim is a G-CSF, not a chemotherapeutic agent. Chemotherapeutic agents directly target and damage cancerous cells, while G-CSFs like filgrastim are used to address the side effects of chemotherapy on the immune system.

Clinical Pearl:
G-CSFs like filgrastim are essential in the management of neutropenia caused by chemotherapy or radiation therapy, promoting neutrophil recovery and reducing the risk of severe infections.

Correct Answer: D (Filgrastim is a granulocyte colony-stimulating factor (G-CSF))

**Answer Explanation:** Filgrastim is a granulocyte colony-stimulating factor (G-CSF), which is a type of biological response modifier that stimulates the production of white blood cells, particularly neutrophils. Filgrastim works by binding to specific receptors on neutrophil precursors in the bone marrow, promoting their differentiation and proliferation, ultimately leading to increased neutrophil count in the peripheral blood. This helps in managing neutropenia caused by chemotherapy or radiation therapy, reducing the risk of severe infections.